Sentinal4D
At Sentinal4D, we believe patients battling cancer, neurodegenerative diseases, and chronic inflammatory syndromes deserve personalized therapeutics.
Pre Seed ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredSep 4, 2021 (5 years old)
About Sentinal4D
We are deploying a biology-first, holistic approach with focus on phenotypic-based drug discovery.
Funding rounds
- Pre Seed · amount undisclosedSource: fundraisingfox.com
- Website created
Founders and team
- CBChris Bakal CEO & CO-FOUNDERsource: sentinal4d.com
- MDMatt De Vries CTO & CO-FOUNDERsource: sentinal4d.com
Companies like Sentinal4D
HHotSpot Therapeutics$100M Series B+ · Nov 2021
SSFA TherapeuticsSeed · Jun 2022
SSynthekine$100M Series B+ · Jan 2023
FFlip TherapeuticsSeed · Sep 2026
MMirador Therapeutics$250M Series B+ · Jan 2026
NNRG Therapeutics$67M Series B+ · Sep 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/sentinal4d (get a free API key).